NovaBay Pharmaceuticals Stock Quote NBY - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.73

Bid

Ask

Volume

4,273,769

0.6895 Day's Range 0.8799

0.6895 52 Week Range 44.80

Market Cap

840.752k

Previous Close

1.94

Open

0.81

Last Trade

10527

0.7002

Last Trade Time

Financial Volume

$ 3,258,068

VWAP

0.762341

Average Volume (3m)

8,837,499

Shares Outstanding

1,151,715

Dividend Yield

PE Ratio

-0.05

Earnings Per Share (EPS)

-14.5

Revenue

14.73M

Net Profit

-16.7M

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novabay.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

NovaBay Pharmaceuticals Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker NBY. The last closing price for NovaBay Pharmaceuticals was $1.94. Over the last year, NovaBay Pharmaceuticals shares have traded in a share price range of $ 0.6895 to $ 44.80.

NovaBay Pharmaceuticals currently has 1,151,715 shares outstanding. The market capitalization of NovaBay Pharmaceuticals is $2.23 million. NovaBay Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.05.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.26	-63.3165829146	1.99	2.2599	0.6895	123381	2.08143857	CS
4	-1.49	-67.1171171171	2.22	2.4521	0.6895	102685	2.16626081	CS
12	-2.4725	-77.2053083528	3.2025	9.079	0.6895	8837499	4.89135555	CS
26	-4.94	-87.1252204586	5.67	9.079	0.6895	5840635	4.89544742	CS
52	-24.2285	-97.0751447403	24.9585	44.8	0.6895	3380036	6.57301265	CS
156	-783.27	-99.9068877551	784	943.25	0.6895	1634594	133.26439762	CS
260	-1346.77	-99.945825603	1347.5	2670.5	0.6895	2054469	734.76240226	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M